Silgan (SLGN) Q2 2024 earnings summary

Executive summary

• Q2 2024 net sales were $1.38 billion, down 3.2% year-over-year, mainly due to lower raw material costs and unfavorable product mix, but volumes improved across all segments as customer destocking ended.

• Adjusted net income per diluted share rose to $0.88 from $0.83 year-over-year, reflecting improved operational performance.

• Gross profit margin improved to 18.5% in Q2 2024 from 17.5% in Q2 2023, driven by productivity and favorable mix.

• Announced agreement to acquire Weener Packaging/Plastics for €838 million, expected to close in Q4 2024, expanding the global dispensing business and expected to enhance margins and organic growth.

• Customer order patterns normalized, ending destocking trends and supporting positive volume inflection.

Financial highlights

• Adjusted EBIT for Q2 2024 was $165.4 million, up from $160.8 million in Q2 2023, driven by higher volumes in all segments.

• Net income for Q2 2024 was $76.1 million, with EPS of $0.71, flat year-over-year.

• Interest and other debt expense decreased to $41.3 million in Q2 2024 from $46.8 million in Q2 2023.

• Six-month net sales were $2.70 billion, down 5.2% year-over-year; net income for the period was $131.3 million.

• Dividends paid in the first half totaled $41.5 million; $7.7 million in share repurchases.

Outlook and guidance

• Full-year 2024 adjusted EPS guidance confirmed at $3.55–$3.75, a 7% increase at midpoint over 2023.

• Free cash flow for 2024 estimated at $375 million, with CapEx of $240 million.

• Q3 2024 adjusted EPS expected at $1.20–$1.30, up from $1.16 in Q3 2023.

• Management expects sufficient liquidity from operations and credit facilities to meet obligations and fund growth, including the Weener acquisition.

• Ongoing evaluation of acquisition opportunities; focus on shareholder value through growth, cost reduction, and capital deployment.